Invention Grant
- Patent Title: Aminooxazole inhibitors of cyclin dependent kinases
- Patent Title (中): 细胞周期蛋白依赖性激酶的氨基恶唑抑制剂
-
Application No.: US14034718Application Date: 2013-09-24
-
Publication No.: US08865709B2Publication Date: 2014-10-21
- Inventor: Laxman S. Desai , Srinivas Chittaboina
- Applicant: Neosome Life Sciences, LLC
- Applicant Address: US MA Bedford
- Assignee: Neosome Life Sciences, LLC
- Current Assignee: Neosome Life Sciences, LLC
- Current Assignee Address: US MA Bedford
- Agency: Foley Hoag LLP
- Main IPC: A61K31/421
- IPC: A61K31/421 ; A61K31/4725 ; A61K31/426 ; A61K31/506 ; A61P35/00 ; A61P1/16 ; A61P9/10 ; A61P37/06 ; A61P3/00 ; A61P17/06 ; A61P3/10 ; A61P17/02 ; A61P29/00 ; A61P25/28 ; C07D263/48 ; C07D413/10 ; C07D277/42 ; C07D417/14 ; C07D417/02 ; C07D237/28 ; C07D237/30 ; C07D241/38 ; C07D239/74 ; C07D217/02 ; C07D217/22 ; C07D217/24 ; C07D487/04 ; C07D413/04 ; C07D295/135 ; C07D401/04
Abstract:
Oxazole derivatives are described. The inventive compounds are useful as kinase inhibitors, and may be used in the treatment of cancer, such as prostate cancer, lung cancer, breast cancer, colon cancer, leukemia, CNS cancer, melanoma, ovarian cancer, and renal cancer.
Public/Granted literature
- US20140051694A1 Aminooxazole Inhibitors of Cyclin Dependent Kinases Public/Granted day:2014-02-20
Information query
IPC分类:
